Position in ZBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$78,653,931
-$49,274,150 QoQ
Shares Held
4,023,219
+14.2% QoQ
Ownership
6.37%
of shares outstanding
% of Portfolio
4.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEA Management Company, LLC holds $1,651,836,644 across 23 Biotechnology names. ZBIO ranks #8 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
3,045,262 | $349,656,982 | |
| 2 | CELC |
Celcuity Inc.
|
2,285,561 | $260,873,932 | |
| 3 | SGP |
SpyGlass Pharma, Inc.
|
7,392,301 | $191,534,518 | |
| 4 | TRVI |
Trevi Therapeutics, Inc.
|
13,222,228 | $157,741,180 | |
| 5 | SVRA |
Savara Inc
|
24,471,264 | $133,613,101 | |
| 6 | GLUE |
Monte Rosa Therapeutics, Inc.
|
7,692,298 | $126,538,302 | |
| 7 | MBX |
MBX Biosciences, Inc.
|
3,614,486 | $107,892,407 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
This page
|
4,023,219 | $78,653,931 |
All Filings in ZBIO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,653,931 | 4,023,219 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $127,928,081 | 3,523,219 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $60,688,561 | 2,733,719 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,489,737 | 2,733,719 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $20,650,189 | 2,613,948 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $21,408,234 | 2,613,948 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $44,228,000 | 2,613,948 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||